About Christopher Wolff
Form D filings for Bioventrix from 2021 to 2023 list Christopher Wolff as executive officer.
Christopher Wolff first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Wolff in the role, so the role may have started earlier or lasted longer.
Bioventrix, Inc.
Executive officer
2021 – 2023 · Mansfield, MA
Develops an investigational heart device for surgeons treating patients with heart failure.
Key Colleagues at Startups
The people Christopher Wolff works with at each company, as listed on that company's latest Form D.
Bioventrix, Inc. · Form D, Apr 4, 2023
RC
Raymond Cohen
Director
Steve Chartier
Executive officer
JD
James Dillon
Executive officer and director
David Richmond
Co-Chief Executive Officer and director
AH
Andrew Hinson
Director
AC
Andrew Coats
Director
BC
Bihua Chen
Director
MT
Michael Taglich
Director
RW
Raphael Wisniewski
Director
RS
Rinda Sama
Director
OY
Ori Ben-Yehuda
Executive officer
WA
William Abbott
Chief Financial Officer